These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 9212363)

  • 1. The CD94/NKG2 C-type lectin receptor complex: involvement in NK cell-mediated recognition of HLA class I molecules.
    López-Botet M; Carretero M; Pérez-Villar J; Bellón T; Llano M; Navarro F
    Immunol Res; 1997; 16(2):175-85. PubMed ID: 9212363
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structure and function of the CD94 C-type lectin receptor complex involved in recognition of HLA class I molecules.
    López-Botet M; Pérez-Villar JJ; Carretero M; Rodríguez A; Melero I; Bellón T; Llano M; Navarro F
    Immunol Rev; 1997 Feb; 155():165-74. PubMed ID: 9059892
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Kinetics and peptide dependency of the binding of the inhibitory NK receptor CD94/NKG2-A and the activating receptor CD94/NKG2-C to HLA-E.
    Valés-Gómez M; Reyburn HT; Erskine RA; López-Botet M; Strominger JL
    EMBO J; 1999 Aug; 18(15):4250-60. PubMed ID: 10428963
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The CD94/NKG2-A inhibitory receptor complex is involved in natural killer cell-mediated recognition of cells expressing HLA-G1.
    Pérez-Villar JJ; Melero I; Navarro F; Carretero M; Bellón T; Llano M; Colonna M; Geraghty DE; López-Botet M
    J Immunol; 1997 Jun; 158(12):5736-43. PubMed ID: 9190923
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The CD94 and NKG2-A C-type lectins covalently assemble to form a natural killer cell inhibitory receptor for HLA class I molecules.
    Carretero M; Cantoni C; Bellón T; Bottino C; Biassoni R; Rodríguez A; Pérez-Villar JJ; Moretta L; Moretta A; López-Botet M
    Eur J Immunol; 1997 Feb; 27(2):563-7. PubMed ID: 9045931
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interleukin-15-induced maturation of human natural killer cells from early thymic precursors: selective expression of CD94/NKG2-A as the only HLA class I-specific inhibitory receptor.
    Mingari MC; Vitale C; Cantoni C; Bellomo R; Ponte M; Schiavetti F; Bertone S; Moretta A; Moretta L
    Eur J Immunol; 1997 Jun; 27(6):1374-80. PubMed ID: 9209487
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Orderly and nonstochastic acquisition of CD94/NKG2 receptors by developing NK cells derived from embryonic stem cells in vitro.
    Lian RH; Maeda M; Lohwasser S; Delcommenne M; Nakano T; Vance RE; Raulet DH; Takei F
    J Immunol; 2002 May; 168(10):4980-7. PubMed ID: 11994449
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The activating form of CD94 receptor complex: CD94 covalently associates with the Kp39 protein that represents the product of the NKG2-C gene.
    Cantoni C; Biassoni R; Pende D; Sivori S; Accame L; Pareti L; Semenzato G; Moretta L; Moretta A; Bottino C
    Eur J Immunol; 1998 Jan; 28(1):327-38. PubMed ID: 9485212
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HLA-E is expressed on trophoblast and interacts with CD94/NKG2 receptors on decidual NK cells.
    King A; Allan DS; Bowen M; Powis SJ; Joseph S; Verma S; Hiby SE; McMichael AJ; Loke YW; Braud VM
    Eur J Immunol; 2000 Jun; 30(6):1623-31. PubMed ID: 10898498
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human natural killer cell receptors involved in MHC class I recognition are disulfide-linked heterodimers of CD94 and NKG2 subunits.
    Lazetic S; Chang C; Houchins JP; Lanier LL; Phillips JH
    J Immunol; 1996 Dec; 157(11):4741-5. PubMed ID: 8943374
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of Ly49E and CD94/NKG2 on fetal and adult NK cells.
    Van Beneden K; Stevenaert F; De Creus A; Debacker V; De Boever J; Plum J; Leclercq G
    J Immunol; 2001 Apr; 166(7):4302-11. PubMed ID: 11254682
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Linkage of the NKG2 and CD94 receptor genes to D12S77 in the human natural killer gene complex.
    Sobanov Y; Glienke J; Brostjan C; Lehrach H; Francis F; Hofer E
    Immunogenetics; 1999 Feb; 49(2):99-105. PubMed ID: 9887346
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The CD94/NKG2C-type lectin receptor complex in recognition of HLA class I molecules.
    López-Botet M; Carretero M; Bellón T; Pérez-Villar JJ; Llano M; Navarro F
    Res Immunol; 1997; 148(3):155-9. PubMed ID: 9255866
    [No Abstract]   [Full Text] [Related]  

  • 14. Structure of CD94 reveals a novel C-type lectin fold: implications for the NK cell-associated CD94/NKG2 receptors.
    Boyington JC; Riaz AN; Patamawenu A; Coligan JE; Brooks AG; Sun PD
    Immunity; 1999 Jan; 10(1):75-82. PubMed ID: 10023772
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD94/NKG2 is the predominant inhibitory receptor involved in recognition of HLA-G by decidual and peripheral blood NK cells.
    Söderström K; Corliss B; Lanier LL; Phillips JH
    J Immunol; 1997 Aug; 159(3):1072-5. PubMed ID: 9233599
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HLA-E binds to natural killer cell receptors CD94/NKG2A, B and C.
    Braud VM; Allan DS; O'Callaghan CA; Söderström K; D'Andrea A; Ogg GS; Lazetic S; Young NT; Bell JI; Phillips JH; Lanier LL; McMichael AJ
    Nature; 1998 Feb; 391(6669):795-9. PubMed ID: 9486650
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Direct binding of purified HLA class I antigens by soluble NKG2/CD94 C-type lectins from natural killer cells.
    Ding Y; Sumitran S; Holgersson J
    Scand J Immunol; 1999 May; 49(5):459-65. PubMed ID: 10320637
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of inhibitory receptors Ly49E and CD94/NKG2 on fetal thymic and adult epidermal TCR V gamma 3 lymphocytes.
    Van Beneden K; De Creus A; Stevenaert F; Debacker V; Plum J; Leclercq G
    J Immunol; 2002 Apr; 168(7):3295-302. PubMed ID: 11907085
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of HLA-E peptide-binding specificity and contact residues in bound peptide required for recognition by CD94/NKG2.
    Miller JD; Weber DA; Ibegbu C; Pohl J; Altman JD; Jensen PE
    J Immunol; 2003 Aug; 171(3):1369-75. PubMed ID: 12874227
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recognition of human histocompatibility leukocyte antigen (HLA)-E complexed with HLA class I signal sequence-derived peptides by CD94/NKG2 confers protection from natural killer cell-mediated lysis.
    Borrego F; Ulbrecht M; Weiss EH; Coligan JE; Brooks AG
    J Exp Med; 1998 Mar; 187(5):813-8. PubMed ID: 9480992
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.